Janssen seeks approval for Stelara in US and Europe to treat Crohn's disease

Janssen Biotech and Janssen-Cilag International (Janssen) have submitted two applications in the US and Europe for approval of Stelara (ustekinumab) to treat adults with moderately to severely active Crohn's disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news